Review of Coronary Late Breaking Trials From the TCT Connect 2020 Virtual Meeting

Giorgio A Medranda; Brian C Case; Jason P Wermers; Natalie Morrison; Charan Yerasi; Brian Forrestal; Chava Chezar-Azerrad; Ron Waksman

doi:10.1016/j.carrev.2020.12.036

Review of Coronary Late Breaking Trials From the TCT Connect 2020 Virtual Meeting

Cardiovasc Revasc Med. 2021 Jul:28:65-70. doi: 10.1016/j.carrev.2020.12.036. Epub 2021 Jan 4.

Authors

Giorgio A Medranda¹, Brian C Case¹, Jason P Wermers¹, Natalie Morrison¹, Charan Yerasi¹, Brian Forrestal¹, Chava Chezar-Azerrad¹, Ron Waksman²

Affiliations

¹ Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America.
² Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America. Electronic address: ron.waksman@medstar.net.

No abstract available

Keywords: Bleeding risk; Drug-eluting stent; Dual antiplatelet therapy; Percutaneous coronary intervention; TCT Connect; Thromboembolic risk; Transcatheter Cardiovascular Therapeutics.

Publication types

Review

MeSH terms

Coronary Artery Disease* / drug therapy
Coronary Artery Disease* / therapy
Drug Therapy, Combination
Drug-Eluting Stents*
Humans
Percutaneous Coronary Intervention* / adverse effects
Platelet Aggregation Inhibitors / therapeutic use
Treatment Outcome

Substances

Platelet Aggregation Inhibitors